Sartorius Stedim Biotech SA 2018 IR
The report summarizes Sartorius Stedim Biotech's financial and operational performance for the fiscal year 2018. The company achieved double-digit growth, with sales revenue increasing by 13.7% in constant currencies to €1,212.2 million and underlying EBITDA rising by 16.1% to €342.4 million. Key operational milestones included significant capacity expansions at manufacturing sites in Puerto Rico, Germany, and France. While the company is exempt from publishing a detailed non-financial statement because its sustainability information is integrated into the report of its parent company, Sartorius AG, it continues to focus on digital transformation, process automation, and expanding its product portfolio.
Company: Sartorius Stedim Biotech SA
Sector: Manufacturing
Country: France
Year: 2018
Type: IR
Pages: 190
Back to company
Sartorius Stedim Biotech SA
Reference Document
The report summarizes Sartorius Stedim Biotech's financial and operational performance for the fiscal year 2018. The company achieved double-digit growth, with sales revenue increasing by 13.7% in constant currencies to €1,212.2 million and underlying EBITDA rising by 16.1% to €342.4 million. Key operational milestones included significant capacity expansions at manufacturing sites in Puerto Rico, Germany, and France. While the company is exempt from publishing a detailed non-financial statement because its sustainability information is integrated into the report of its parent company, Sartorius AG, it continues to focus on digital transformation, process automation, and expanding its product portfolio.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Jan 1, 2018 - Dec 31, 2018
Fiscal Year
2018
Published
Feb 18, 2019
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees